Emmes releases standalone cloud software product, Advantage eClinical

By The Science Advisory Board staff writers

May 13, 2022 -- Emmes will unveil the third generation of its Advantage eClinical software at the Society for Clinical Trials annual meeting in San Diego. This newly updated program functions as a standalone cloud software product, with improved utility and insights for clinical trial sponsors.

The platform comes equipped with apps related to study design, electronic data capture, randomization and trial supply management, patient-reported outcomes, safety data and reporting, risk monitoring, source data verification, and specimen tracking. The platform will be available for purchase alongside data consultation services or as a standalone product.

This new version of Advantage eClinical enables higher quality data and facilitates the oversight of clinical trials in a timely manner, reducing costs as well. Furthermore, the new platform promotes rapid study builds with greater flexibility for a variety of clinical trial sponsor companies.

Emmes CRO acquires Orphan Reach
Clinical Research Organization (CRO) Emmes, a portfolio company of Behrman Capital, announced it has acquired Orphan Reach, an organization specialized...

Copyright © 2022 scienceboard.net

International Society for Cell and Gene Therapy Annual Meeting
May 4 - June 7
San Francisco, California United States
Interphex 2022 Conference
May 24-26
New York, New York United States
American Society for Mass Spectrometry Annual Conference
June 5-9
Minneapolis, Minnesota United States
American Society for Microbiology Microbe Meeting
June 9-13
District of Columbia United States
HPLC 2022
June 18-23
San Diego, California United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter